Why We Invested: Pioneer Square Labs Studio 3
As early-stage investors (and former founders ourselves), we know first-hand how difficult it can be to launch a successful startup. Which is why we have always been keen supporters of the incubator or studio model as a means to help entrepreneurs think through some of the difficult questions that invariably get missed at the earliest, most formative stages of a company.
The Year Ahead - My Thoughts on 2023 and What Brought Us Here
The last few years in the private equity markets culminated in what I call "Moral Hazard at Scale." However, as the Great Reset begins in 2023, there are some encouraging signs that reality and rationality are starting to take hold in the market. This has me very bullish and why I believe now is the time to be investing in private capital markets. Those with conviction and patience should be handsomely rewarded.
The Kids Are Alright
Over the past two quarters, industry participants and research analysts alike have all put forward their wisdom on what the venture capital landscape will look like in the coming months and year. Set against a backdrop of a public market correction, increasing inflation, rising interest rates and political unrest, it would be easy to sound the horns of Armageddon and “let slip the dogs of war.”
The dreamer’s disease
The Dreamer's Disease, a narcotic like state that infects all entrepreneurs. How have founders managed this, in order to further their businesses.
The Creator Gene
The traits that make up what I call the “Creator Gene” are many and varied. A tendency toward natural leadership, a disregard for tradition, a willingness to fail, excessive self-motivation, competitiveness, and a deep, deep curiosity – all bound together by a little OCD.